Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03997448
Title Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nataliya Uboha
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.